Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Alzheimer's Disease

  Free Subscription

Articles published in Neurosci Lett

Retrieve available abstracts of 79 articles:
HTML format

Single Articles

    June 2022
  1. WANG J, Wen C, Li J, Chen J, et al
    Automated quantification of brain connectivity in Alzheimer's disease using ClusterMetric.
    Neurosci Lett. 2022 Jun 10:136724. doi: 10.1016/j.neulet.2022.136724.
    PubMed     Abstract available

  2. MA X, Liu L, Meng J
    Retraction notice to "MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease" [Neurosci. Lett. 661 (2017) 57-62].
    Neurosci Lett. 2022;783:136703.

  3. AAMERI R, Ghorbani H, Reza Bazrafshan H, Zahra Gharib F, et al
    Iranian thyme honey plays behavioral, cellular and molecular important roles as an amazing preventive and therapeutic agent in the brain of Alzheimer's rat model.
    Neurosci Lett. 2022;783:136702.
    PubMed     Abstract available

    May 2022
  4. HU Y, Wen C, Cao G, Wang J, et al
    Brain network connectivity feature extraction using deep Learning for Alzheimer's disease classification.
    Neurosci Lett. 2022 May 2:136673. doi: 10.1016/j.neulet.2022.136673.
    PubMed     Abstract available

    April 2022
  5. WANG Y, Yang Y, Liu Y, Guo A, et al
    Cognitive impairments in type 1 diabetes mellitus model mice are associated with synaptic protein disorders.
    Neurosci Lett. 2022;777:136587.
    PubMed     Abstract available

    February 2022
  6. PIJEWSKI RS, Sutter PA, Duszak VA, Singh N, et al
    Distinct profiles of cellular senescence-associated gene expression in the aged, diseased or injured central nervous system.
    Neurosci Lett. 2022;772:136480.
    PubMed     Abstract available

  7. LI Y, Han X, Fan H, Sun J, et al
    Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease.
    Neurosci Lett. 2022 Feb 12:136531. doi: 10.1016/j.neulet.2022.136531.
    PubMed     Abstract available

  8. AN Y, Qi Y, Li Y, Li Z, et al
    Activation of the sigma-1 receptor attenuates blood-brain barrier disruption by inhibiting amyloid deposition in Alzheimer's disease mice.
    Neurosci Lett. 2022 Feb 11:136528. doi: 10.1016/j.neulet.2022.136528.
    PubMed     Abstract available

    January 2022
  9. IMA X, Liu L, Meng J
    Expression of concern: MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease.
    Neurosci Lett. 2022;769:136229.

  10. CHENFEI Z, Haizhen Y, Jie X, Na Z, et al
    Effects of aerobic exercise on hippocampal SUMOylation in APP/PS1 transgenic mice.
    Neurosci Lett. 2022;767:136303.
    PubMed     Abstract available

  11. QIAN C, Zhang M
    RTN3 - ASC interaction: The potential mechanism behind diabetes-induced cortical neuritic dystrophy.
    Neurosci Lett. 2022;766:136333.
    PubMed     Abstract available

    December 2021
  12. XUE YY, Chen YH, Lin RR, Huang HF, et al
    Alzheimer's disease susceptibility locus in CD2AP is associated with increased cerebrospinal fluid tau levels in mild cognitive impairment.
    Neurosci Lett. 2021 Dec 24:136419. doi: 10.1016/j.neulet.2021.136419.
    PubMed     Abstract available

  13. WANG M, Ren Q, Shi Y, Shu H, et al
    The Effect of Alzheimer's Disease Risk Factors on Brain Aging in normal Chineses: Cognitive Aging and Cognitive Reserve.
    Neurosci Lett. 2021 Dec 16:136398. doi: 10.1016/j.neulet.2021.136398.
    PubMed     Abstract available

  14. LAI X, Hu J, Liu H, Lan L, et al
    A short peptide from sAPPalpha binding to BACE1-APP action site rescues Alzheimer-like pathology.
    Neurosci Lett. 2021 Dec 13:136397. doi: 10.1016/j.neulet.2021.136397.
    PubMed     Abstract available

    November 2021
  15. GEORGE B, D Gokhale S, Yaswanth PM, Vijayan A, et al
    Identification of Alzheimer associated differentially expressed gene through microarray data and transfer learning-based image analysis.
    Neurosci Lett. 2021;766:136357.
    PubMed     Abstract available

  16. ZHOU X, Wang Y, Lv S, Li Y, et al
    Transcranial magnetic stimulation for sleep disorders in Alzheimer's disease: A double-blind, randomized, and sham-controlled pilot study.
    Neurosci Lett. 2021;766:136337.
    PubMed     Abstract available

  17. ZHANG Y, Zhao Y, Zhang J, Gao Y, et al
    Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Abeta1-42-induced microglia cells.
    Neurosci Lett. 2021;764:136206.
    PubMed     Abstract available

    October 2021
  18. ZHU Z, Liu Y, Li X, Zhang L, et al
    GPNMB mitigates Alzheimer's disease and enhances autophagy via suppressing the mTOR signal.
    Neurosci Lett. 2021 Oct 22:136300. doi: 10.1016/j.neulet.2021.136300.
    PubMed     Abstract available

  19. BANG S, Kuen Song J, Shin SW, Hee Lee K, et al
    Human Serum Albumin Fusion Protein as Therapeutics for Targeting Amyloid Beta in Alzheimer's Diseases.
    Neurosci Lett. 2021 Oct 18:136298. doi: 10.1016/j.neulet.2021.136298.
    PubMed     Abstract available

    September 2021
  20. CASTILLO-MARIQUEO L, Gimenez-Llort L
    Kyphosis and bizarre patterns impair spontaneous gait performance in end-of-life mice with Alzheimer's disease pathology while gait is preserved in normal aging.
    Neurosci Lett. 2021 Sep 30:136280. doi: 10.1016/j.neulet.2021.136280.
    PubMed     Abstract available

  21. GAO F, Liu T, Tuo M, Chi S, et al
    The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
    Neurosci Lett. 2021;765:136247.
    PubMed     Abstract available

  22. LU X, Zhang Y, Li H, Jin Y, et al
    Nicotine prevents in vivo Abeta toxicity in Caenorhabditis elegans via SKN-1.
    Neurosci Lett. 2021;761:136114.
    PubMed     Abstract available

  23. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    PubMed     Abstract available

  24. RADAGHDAM S, Karamad V, Nourazarian A, Shademan B, et al
    Molecular mechanisms of sex hormones in the development and progression of Alzheimer's disease.
    Neurosci Lett. 2021 Sep 6:136221. doi: 10.1016/j.neulet.2021.136221.
    PubMed     Abstract available

    August 2021
  25. RIZZI L, Balthazar MLF
    Mini-review: The suspected non-Alzheimer's disease pathophysiology.
    Neurosci Lett. 2021 Aug 31:136208. doi: 10.1016/j.neulet.2021.136208.
    PubMed     Abstract available

  26. KIM TA, Chen L, Ge S
    The interplay of neurovasculature and adult hippocampal neurogenesis.
    Neurosci Lett. 2021;760:136071.
    PubMed     Abstract available

  27. WEI X, Xie L, Du P, Zhao Z, et al
    Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's Disease.
    Neurosci Lett. 2021 Aug 23:136196. doi: 10.1016/j.neulet.2021.136196.
    PubMed     Abstract available

  28. ZHAO N, Xu B
    The beneficial effect of exercise against Alzheimer's disease may result from improved brain glucose metabolism.
    Neurosci Lett. 2021 Aug 18:136182. doi: 10.1016/j.neulet.2021.136182.
    PubMed     Abstract available

    July 2021
  29. SHENG J, Wang L, Cheng H, Zhang Q, et al
    Strategies for multivariate analyses of imaging genetics study in Alzheimer's disease.
    Neurosci Lett. 2021;762:136147.
    PubMed     Abstract available

  30. YUE L, Liu P, Ma N, Xu Y, et al
    Interaction between extracellular ATP5A1 and LPS alleviates LPS-induced neuroinflammation in mice.
    Neurosci Lett. 2021;758:136005.
    PubMed     Abstract available

  31. AREZOUMANDAN S, Cai X, Kalkarni P, Davis SA, et al
    Hippocampal neurobiology and function in an aged mouse model of TDP-43 proteinopathy in an APP/PSEN1 background.
    Neurosci Lett. 2021;758:136010.
    PubMed     Abstract available

  32. SUN B, Yao J, Chen AW, Estillore JP, et al
    Genetically and pharmacologically limiting RyR2 open time prevents neuronal hyperactivity of hippocampal CA1 neurons in brain slices of 5xFAD mice.
    Neurosci Lett. 2021;758:136011.
    PubMed     Abstract available

  33. WANDER CM, Song J
    The Neurogenic Niche in Alzheimer's disease.
    Neurosci Lett. 2021 Jul 13:136109. doi: 10.1016/j.neulet.2021.136109.
    PubMed     Abstract available

    June 2021
  34. SINGULANI MP, De Paula VJR, Forlenza OV
    Mitochondrial dysfunction in Alzheimer's disease: therapeutic implications of lithium.
    Neurosci Lett. 2021 Jun 20:136078. doi: 10.1016/j.neulet.2021.136078.
    PubMed     Abstract available

  35. HAUSSMANN R, Noppes F, Brandt MD, Bauer M, et al
    Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?
    Neurosci Lett. 2021 Jun 10:136044. doi: 10.1016/j.neulet.2021.136044.
    PubMed     Abstract available

  36. ANDROVICOVA R, Pfaus JG, Ovsepian SV
    Estrogen Pendulum in Schizophrenia and Alzheimer's Disease: Review of Therapeutic Benefits and Outstanding Questions.
    Neurosci Lett. 2021 Jun 8:136038. doi: 10.1016/j.neulet.2021.136038.
    PubMed     Abstract available

    May 2021
  37. DAINI E, Secco V, Liao W, Zoli M, et al
    A regional and cellular analysis of the early intracellular and extracellular accumulation of Abeta in the brain of 5XFAD mice.
    Neurosci Lett. 2021;754:135869.
    PubMed     Abstract available

  38. HE B, Wang L, Xu B, Zhang Y, et al
    Association between CSF Abeta42 and amyloid negativity in patients with different stage mild cognitive impairment.
    Neurosci Lett. 2021;754:135765.
    PubMed     Abstract available

  39. LAKSHMI S, Raghu SV, Elumalai P, Sivan S, et al
    Alkoxylglycerol enhanced activity of Oxyresveratrol in Alzheimer's disease by rescuing Tau protein.
    Neurosci Lett. 2021 May 20:135981. doi: 10.1016/j.neulet.2021.135981.
    PubMed     Abstract available

  40. ZARETSKY DV, Zaretskaia MV
    Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer's disease.
    Neurosci Lett. 2021;756:135959.
    PubMed     Abstract available

  41. ZHANG H, Ge H, Li K
    Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-beta induced neurotoxicity.
    Neurosci Lett. 2021 May 9:135953. doi: 10.1016/j.neulet.2021.135953.
    PubMed     Abstract available

  42. SHAMSIPOUR S, Sharifi G, Taghian F
    Impact of interval training with probiotic (L. plantarum / Bifidobacterium bifidum) on passive avoidance test, ChAT and BDNF in the hippocampus of rats with Alzheimer's disease.
    Neurosci Lett. 2021;756:135949.
    PubMed     Abstract available

    April 2021
  43. ARIOZ BI, Tufekci KU, Olcum M, Durur DY, et al
    Proteome profiling of neuron-derived exosomes in Alzheimer's disease reveals hemoglobin as a potential biomarker.
    Neurosci Lett. 2021;755:135914.
    PubMed     Abstract available

  44. OVSEPIAN SV, O'Leary VB, Hoschl C, Zaborszky L, et al
    Integrated Phylogeny of the Human Brain and Pathobiology of Alzheimer's Disease: A Unifying Hypothesis.
    Neurosci Lett. 2021 Apr 13:135895. doi: 10.1016/j.neulet.2021.135895.
    PubMed     Abstract available

  45. GKANATSIOU E, Sahlin C, Portelius E, Johannesson M, et al
    Characterization of monomeric and soluble aggregated Abeta in Down's syndrome and Alzheimer's disease brains.
    Neurosci Lett. 2021 Apr 10:135894. doi: 10.1016/j.neulet.2021.135894.
    PubMed     Abstract available

  46. RASHTIANI S, Goudarzi I, Jafari A, Rohampour K, et al
    Adenosine monophosphate activated protein kinase (AMPK) is essential for the memory improving effect of adiponectin.
    Neurosci Lett. 2021;749:135721.
    PubMed     Abstract available

    February 2021
  47. SANTOS-GIL DF, Arboleda G, Sandoval-Hernandez AG
    Retinoid X Receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2021 Feb 20:135764. doi: 10.1016/j.neulet.2021.135764.
    PubMed     Abstract available

  48. GIL L, Nino SA, Capdeville G, Jimenez-Capdeville ME, et al
    Neurosci Lett. 2021 Feb 18:135741. doi: 10.1016/j.neulet.2021.135741.
    PubMed     Abstract available

    Evaluation of fluid channels in the human dura and superior sagittal sinus in older patients.
    Neurosci Lett. 2021;746:135649.
    PubMed     Abstract available

  50. LIM KH, Kim SH, Yang S, Chun S, et al
    Advances in multiplex PCR for Alzheimer's disease diagnostics targeting CDK genes.
    Neurosci Lett. 2021 Feb 15:135715. doi: 10.1016/j.neulet.2021.135715.
    PubMed     Abstract available

  51. XU L, Dong Q, Xu L, Zou W, et al
    The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: a case-control study.
    Neurosci Lett. 2021 Feb 9:135710. doi: 10.1016/j.neulet.2021.135710.
    PubMed     Abstract available

    January 2021
  52. LIANG C, Mu Y, Tian H, Wang D, et al
    MicroRNA-140 silencing represses the incidence of Alzheimer's disease.
    Neurosci Lett. 2021 Jan 30:135674. doi: 10.1016/j.neulet.2021.135674.
    PubMed     Abstract available

  53. ZHANG B, Wu L, Zhu Q, Dong Y, et al
    Donepezil attenuates the development of morphine tolerance in rats with cancer-induced bone pain: the role of cortical N-methyl-D-aspartate receptors.
    Neurosci Lett. 2021 Jan 28:135678. doi: 10.1016/j.neulet.2021.135678.
    PubMed     Abstract available

  54. WANG Y, Sheng H, Zhao J, Guo L, et al
    Changes in the prefrontal cortex after the hippocampus was injected with Abeta25-35 via the P35/P25-CDK5-Tau hyperphosphorylation signaling pathway.
    Neurosci Lett. 2021;741:135453.
    PubMed     Abstract available

  55. DIXIT MP, Rahmatkar SN, Raut P, Umekar MJ, et al
    Evidences for agmatine alterations in Abeta1-42induced memory impairment in mice.
    Neurosci Lett. 2021;740:135447.
    PubMed     Abstract available

    December 2020
  56. WANG J, Guo MN, Liu ZZ, Ma SF, et al
    PGC-1alpha reduces Amyloid-beta deposition in Alzheimer's disease: Effect of increased VDR expression.
    Neurosci Lett. 2020;744:135598.
    PubMed     Abstract available

  57. TIAN Z, Dong Q, Wu T, Guo J, et al
    MicroRNA-20b-5p aggravates neuronal apoptosis induced by beta-Amyloid via down-regulation of Ras homolog family member C in Alzheimer's disease.
    Neurosci Lett. 2020 Dec 2:135542. doi: 10.1016/j.neulet.2020.135542.
    PubMed     Abstract available

    November 2020
  58. SONG X, Chen J, Hou Z, Xie N, et al
    Antimicrobial therapy and the potential mechanisms in Alzheimer's disease.
    Neurosci Lett. 2020 Nov 6:135464. doi: 10.1016/j.neulet.2020.135464.
    PubMed     Abstract available

    September 2020
  59. ZHAO A, Li Y, Deng Y
    TNF receptors are associated with tau pathology and conversion to Alzheimer's dementia in subjects with mild cognitive impairment.
    Neurosci Lett. 2020 Sep 15:135392. doi: 10.1016/j.neulet.2020.135392.
    PubMed     Abstract available

    June 2020
  60. TANG Y, Han Y, Yu H, Zhang B, et al
    Increased GABAergic Development in iPSC-Derived Neurons from Patients with Sporadic Alzheimer's Disease.
    Neurosci Lett. 2020 Jun 29:135208. doi: 10.1016/j.neulet.2020.135208.
    PubMed     Abstract available

    May 2020
  61. LIM B, Li QX, Rowe C, Dhiman K, et al
    Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Abeta load and cerebrospinal fluid Abeta in a pilot study of Alzheimer's disease.
    Neurosci Lett. 2020 May 22:135078. doi: 10.1016/j.neulet.2020.135078.
    PubMed     Abstract available

  62. LIU HJ, Li XY, Chen H, Yu HL, et al
    Identification of susceptibility loci for cognitive impairment in a cohort of Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2020 May 10:135034. doi: 10.1016/j.neulet.2020.135034.
    PubMed     Abstract available

  63. DOULAH A, Mahmoodi G, Borujeni MP
    Evaluation of the Pre-Treatment Effect of Centella Asiatica Medicinal Plants on Long-Term potentiation (LTP) in Rat Model of Alzheimer's Disease.
    Neurosci Lett. 2020 May 5:135026. doi: 10.1016/j.neulet.2020.135026.
    PubMed     Abstract available

  64. KONG Y, Peng Q, Lv N, Yuan J, et al
    Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer's disease via activation of adenosine A1 receptor.
    Neurosci Lett. 2020 May 1:135016. doi: 10.1016/j.neulet.2020.135016.
    PubMed     Abstract available

    April 2020
  65. ACERO G, Garay C, Venegas D, Ortega E, et al
    Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid beta 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice.
    Neurosci Lett. 2020;724:134876.
    PubMed     Abstract available

  66. LIU Y, Xu Y, Li M, Pan D, et al
    Multi-target PET evaluation in APP/PS1/tau mouse model of Alzheimer's disease.
    Neurosci Lett. 2020 Apr 8:134938. doi: 10.1016/j.neulet.2020.134938.
    PubMed     Abstract available

    February 2020
  67. ZHANG Z, Gao W, Wang X, Zhang D, et al
    Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APPPS1 mice.
    Neurosci Lett. 2020;720:134749.
    PubMed     Abstract available

    January 2020
  68. LI M, Meng Y, Chu B, Shen Y, et al
    Orexin-A exacerbates Alzheimer's disease by inducing mitochondrial impairment.
    Neurosci Lett. 2020;718:134741.
    PubMed     Abstract available

    December 2019
  69. SUN X, Nie B, Zhao S, Ai L, et al
    Distinct relationships of amyloid-beta and tau deposition to cerebral glucose metabolic networks in Alzheimer's disease.
    Neurosci Lett. 2019;717:134699.
    PubMed     Abstract available

  70. LIU Y, Fang S, Liu LM, Zhu Y, et al
    Hearing loss is an early biomarker in APP/PS1 Alzheimer's disease mice.
    Neurosci Lett. 2019;717:134705.
    PubMed     Abstract available

  71. SINGH A, Agarwal S, Singh S
    Age related neurodegenerative Alzheimer's disease: Usage of traditional herbs in therapeutics.
    Neurosci Lett. 2019 Dec 6:134679. doi: 10.1016/j.neulet.2019.134679.
    PubMed     Abstract available

    November 2019
  72. WANG L, Gao T, Cai T, Li K, et al
    Cerebrospinal fluid levels of YKL-40 in prodromal Alzheimer's disease.
    Neurosci Lett. 2019 Nov 30:134658. doi: 10.1016/j.neulet.2019.134658.
    PubMed     Abstract available

  73. LU X, Moeini M, Li B, Thorin E, et al
    Hypertension accelerates cerebral tissue PO2 disruption in Alzheimer's disease.
    Neurosci Lett. 2019 Nov 11:134626. doi: 10.1016/j.neulet.2019.134626.
    PubMed     Abstract available

    August 2019
  74. NONAKA S, Nakanishi H
    Microglial clearance of focal apoptotic synapses.
    Neurosci Lett. 2019;707:134317.
    PubMed     Abstract available

  75. BALU D, Karstens AJ, Loukenas E, Maldonado Weng J, et al
    The role of APOE in transgenic mouse models of AD.
    Neurosci Lett. 2019;707:134285.
    PubMed     Abstract available

    July 2019
  76. PEREZ-ROCA L, Prada-Dacasa P, Segu-Verges C, Gamez-Valero A, et al
    Glucocerebrosidase regulators SCARB2 and TFEB are up-regulated in Lewy body disease brain.
    Neurosci Lett. 2019;706:164-168.
    PubMed     Abstract available

    June 2019
  77. YAMAGUCHI Y, Ayaki T, Li F, Tsujimura A, et al
    Phosphorylated NF-kappaB subunit p65 aggregates in granulovacuolar degeneration and neurites in neurodegenerative diseases with tauopathy.
    Neurosci Lett. 2019;704:229-235.
    PubMed     Abstract available

    May 2019
  78. XIA W
    gamma-Secretase and its modulators: Twenty years and beyond.
    Neurosci Lett. 2019;701:162-169.
    PubMed     Abstract available

    April 2019
  79. PARKER J, Mozaffar T, Messmore A, Deignan JL, et al
    Homozygosity for the A431E mutation in PSEN1 presenting with a relatively aggressive phenotype.
    Neurosci Lett. 2019;699:195-198.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.